Among the genes responsible for somatic mutations in non‐small‐cell lung cancer (NSCLC), the most frequent driver oncogenes were epidermal growth factor receptor (EGFR), v‐Ki‐ras2 Kirsten rat sarcoma (KRAS), and tumor protein p53 (TP53). This evidence concerns the gene TP53 and non-small cell lung carcinoma.